Vascular Biogenics Ltd. - Ordinary Shares (VBLT): Price and Financial Metrics
Vascular Biogenics Ltd. - Ordinary Shares (VBLT)
Today's Latest Price: $1.37 USD
0.06 (-4.20%)
Updated Feb 14 12:00am
Add VBLT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 215 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
VBLT Stock Summary
- For VBLT, its debt to operating expenses ratio is greater than that reported by only 0.37% of US equities we're observing.
- VBLT's price/sales ratio is 85.26; that's higher than the P/S ratio of 97.44% of US stocks.
- As for revenue growth, note that VBLT's revenue has grown -95.78% over the past 12 months; that beats the revenue growth of just 0.6% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Vascular Biogenics Ltd are FPRX, ASMB, EVGN, OTIC, and CNCE.
- Visit VBLT's SEC page to see the company's official filings. To visit the company's web site, go to www.vblrx.com.
VBLT Daily Price Range
VBLT 52-Week Price Range
VBLT Stock Price Chart More Charts
VBLT Price/Volume Stats
| Current price | $1.37 | 52-week high | $1.90 |
| Prev. close | $1.43 | 52-week low | $0.93 |
| Day low | $1.30 | Volume | 110,600 |
| Day high | $1.45 | Avg. volume | 121,926 |
| 50-day MA | $1.33 | Dividend yield | N/A |
| 200-day MA | $1.27 | Market Cap | 49.16M |
Vascular Biogenics Ltd. - Ordinary Shares (VBLT) Company Bio
Vascular Biogenics Limited is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of treatments for cancer and immune-inflammatory diseases. The company was founded in 2000 and is based in Or Yehuda, Israel.
Loading social stream, please wait...